Loading video...

Video Failed to Load

There was a problem loading this video. This could be due to a temporary network issue or the video might be unavailable.

🚨 Peer-reviewed and published: the largest observational human study on ivermectin in cancer to date, via the International Institute of Anticancer Research. 84.4% of patients saw complete remission, tumor shrinkage, or halted growth. Here's Nicolas Hulscher's breakdown:

Jack Posobiec

3,285,761 subscribers

56,545 views • 1 day ago •via X (Twitter)

Health & Wellness Science & Technology

Anya Rossi• Live Now

Private livecam show

1 Comments

Jack Posobiec1 day ago

The Wellness Company’s Medical Board, led by Dr. Peter McCullough is on the cutting edge of treating serious diseases. Try their gold-standard, US-compounded Ivermectin + Mebendazole Parasite Cleanse. Click below, code POSO saves up to $60 + Free Shipping. 🇺🇸 Only.

Related Videos

The LARGEST human ivermectin cancer study EVER conducted found 84% of cancer patients declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH. Our study is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research. The tide is turning.

The LARGEST human ivermectin cancer study EVER conducted found 84% of cancer patients declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH. Our study is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research. The tide is turning.

Nicolas Hulscher, MPH

1,963,753 views • 3 months ago

Nearly HALF of cancer patients declared COMPLETE REMISSION or TUMOR SHRINKAGE in the largest human ivermectin cancer study ever conducted. Our study is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research.

Nearly HALF of cancer patients declared COMPLETE REMISSION or TUMOR SHRINKAGE in the largest human ivermectin cancer study ever conducted. Our study is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research.

Nicolas Hulscher, MPH

53,318 views • 3 months ago

Mel Gibson was NOT lying to Joe Rogan… our peer-reviewed study found 84.4% of cancer patients taking ivermectin + mebendazole declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED CANCER GROWTH. The study just became the #1 RESULT ON GOOGLE. Censorship has FAILED.

Mel Gibson was NOT lying to Joe Rogan… our peer-reviewed study found 84.4% of cancer patients taking ivermectin + mebendazole declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED CANCER GROWTH. The study just became the #1 RESULT ON GOOGLE. Censorship has FAILED.

Nicolas Hulscher, MPH

82,893 views • 3 months ago

"I know a GENERAL and a WORLD-RENOWNED ATHLETE that had STAGE IV CANCER... they credit IVERMECTIN for CLEARNESS of health." And now we have the peer-reviewed data... 84% of cancer patients taking ivermectin declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH.

"I know a GENERAL and a WORLD-RENOWNED ATHLETE that had STAGE IV CANCER... they credit IVERMECTIN for CLEARNESS of health." And now we have the peer-reviewed data... 84% of cancer patients taking ivermectin declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH.

Nicolas Hulscher, MPH

22,968 views • 2 months ago

The single LARGEST human study of ivermectin and mebendazole in cancer patients found that the VAST MAJORITY (84.4%) declared CANCER DISAPPEARANCE, TUMOR SHRINKAGE, or CANCER STABILIZATION.

The single LARGEST human study of ivermectin and mebendazole in cancer patients found that the VAST MAJORITY (84.4%) declared CANCER DISAPPEARANCE, TUMOR SHRINKAGE, or CANCER STABILIZATION.

Nicolas Hulscher, MPH

437,760 views • 5 months ago

We found 84.4% of cancer patients taking ivermectin and mebendazole for 6 months declared either COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH. It’s no surprise the CIA BURIED a 1950s study for over HALF A CENTURY showing anti-parasitics disrupt cancer growth.

We found 84.4% of cancer patients taking ivermectin and mebendazole for 6 months declared either COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH. It’s no surprise the CIA BURIED a 1950s study for over HALF A CENTURY showing anti-parasitics disrupt cancer growth.

Nicolas Hulscher, MPH

175,994 views • 4 months ago

Mel Gibson isn't lying... our new study found 84% of cancer patients taking ivermectin + mebendazole declared either COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH after 6 months.

Mel Gibson isn't lying... our new study found 84% of cancer patients taking ivermectin + mebendazole declared either COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH after 6 months.

Nicolas Hulscher, MPH

1,962,520 views • 4 months ago

Mel Gibson wasn’t lying when he said three of his friends’ Stage IV cancers disappeared after taking ivermectin… Our study found 84% of cancer patients taking ivermectin declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED CANCER GROWTH.

Mel Gibson wasn’t lying when he said three of his friends’ Stage IV cancers disappeared after taking ivermectin… Our study found 84% of cancer patients taking ivermectin declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED CANCER GROWTH.

Nicolas Hulscher, MPH

43,787 views • 2 months ago

It's no wonder the CIA classified a 1950s study for over HALF A CENTURY showing anti-parasitics suppress cancer growth… We found 84% of cancer patients taking ivermectin + mebendazole declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED CANCER GROWTH after 6 months.

It's no wonder the CIA classified a 1950s study for over HALF A CENTURY showing anti-parasitics suppress cancer growth… We found 84% of cancer patients taking ivermectin + mebendazole declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED CANCER GROWTH after 6 months.

Nicolas Hulscher, MPH

44,500 views • 21 days ago

The LARGEST systematic review study ever conducted on ivermectin use in cancer patients identified 14 distinct anticancer mechanisms across 12 cancer types and found no safety concerns. Meanwhile, a recent study reported COMPLETE REMISSION of Stage IV cancers with fenbendazole.

The LARGEST systematic review study ever conducted on ivermectin use in cancer patients identified 14 distinct anticancer mechanisms across 12 cancer types and found no safety concerns. Meanwhile, a recent study reported COMPLETE REMISSION of Stage IV cancers with fenbendazole.

Nicolas Hulscher, MPH

90,372 views • 7 months ago

🚨NEARLY HALF OF CANCER PATIENTS TAKING IVERMECTIN + MEBENDAZOLE REPORTED CANCER DISAPPEARANCE OR TUMOR REGRESSION AFTER 6 MONTHS 84.4% EXPERIENCED CLINICAL BENEFIT 32.8% REPORTED NO EVIDENCE OF DISEASE 15.6% REPORTED TUMOR REGRESSION 36.1% REPORTED STABLE DISEASE Our study represents the largest and most compelling clinical signal to date supporting antiparasitic therapy in cancer.

🚨NEARLY HALF OF CANCER PATIENTS TAKING IVERMECTIN + MEBENDAZOLE REPORTED CANCER DISAPPEARANCE OR TUMOR REGRESSION AFTER 6 MONTHS 84.4% EXPERIENCED CLINICAL BENEFIT 32.8% REPORTED NO EVIDENCE OF DISEASE 15.6% REPORTED TUMOR REGRESSION 36.1% REPORTED STABLE DISEASE Our study represents the largest and most compelling clinical signal to date supporting antiparasitic therapy in cancer.

Joe Tippens

56,068 views • 5 months ago

Mel Gibson wasn't lying to Joe Rogan... and the largest human ivermectin cancer study to date just confirmed it. We found 84.4% of cancer patients taking ivermectin for 6 months declared their cancer: DISAPPEARED (32.8%) SHRUNK (15.6%) STOPPED SPREADING (36.1%)

Mel Gibson wasn't lying to Joe Rogan... and the largest human ivermectin cancer study to date just confirmed it. We found 84.4% of cancer patients taking ivermectin for 6 months declared their cancer: DISAPPEARED (32.8%) SHRUNK (15.6%) STOPPED SPREADING (36.1%)

Nicolas Hulscher, MPH

125,156 views • 2 months ago

Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date. After just 6 months, 84.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics. Clinical trials are now NECESSARY.

Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date. After just 6 months, 84.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics. Clinical trials are now NECESSARY.

Nicolas Hulscher, MPH

100,804 views • 5 months ago

This should be front-page news EVERYWHERE. The LARGEST real-world study of ivermectin + mebendazole in cancer patients found that nearly HALF declared CANCER DISAPPEARANCE or TUMOR SHRINKAGE after just 6 months. 84.4% experienced clinical benefit. This was not surprising, as HUNDREDS of preclinical studies have shown anti-parasitics attack tumors via 12 distinct mechanisms across more than 12 cancer types. Brad Smith

This should be front-page news EVERYWHERE. The LARGEST real-world study of ivermectin + mebendazole in cancer patients found that nearly HALF declared CANCER DISAPPEARANCE or TUMOR SHRINKAGE after just 6 months. 84.4% experienced clinical benefit. This was not surprising, as HUNDREDS of preclinical studies have shown anti-parasitics attack tumors via 12 distinct mechanisms across more than 12 cancer types. Brad Smith

Nicolas Hulscher, MPH

19,219 views • 5 months ago

Nearly One in Two Cancer Patients Saw Their Cancer Go Into Remission or Improve. Let That Sink In. Not stable. Not managed. Remission or improvement — in a real-world cohort of nearly 200 cancer patients on off-label ivermectin and mebendazole. The study is under peer review. The drugs are already on pharmacy shelves. The National Cancer Institute has an obligation to take this to a large-scale controlled trial immediately. Join the Fight: Courtesy of Newsmax NEWSMAX, Katrina Szish KATRINA SZISH, Bob Brooks Bob Brooks #MedicalFreedom

Nearly One in Two Cancer Patients Saw Their Cancer Go Into Remission or Improve. Let That Sink In. Not stable. Not managed. Remission or improvement — in a real-world cohort of nearly 200 cancer patients on off-label ivermectin and mebendazole. The study is under peer review. The drugs are already on pharmacy shelves. The National Cancer Institute has an obligation to take this to a large-scale controlled trial immediately. Join the Fight: Courtesy of Newsmax NEWSMAX, Katrina Szish KATRINA SZISH, Bob Brooks Bob Brooks #MedicalFreedom

McCullough Foundation

44,547 views • 4 months ago

🚨NEARLY HALF OF CANCER PATIENTS TAKING IVERMECTIN + MEBENDAZOLE REPORTED CANCER DISAPPEARANCE OR TUMOR REGRESSION AFTER 6 MONTHS 84.4% EXPERIENCED CLINICAL BENEFIT 32.8% REPORTED NO EVIDENCE OF DISEASE 15.6% REPORTED TUMOR REGRESSION 36.1% REPORTED STABLE DISEASE Our study represents the largest and most compelling clinical signal to date supporting antiparasitic therapy in cancer. McCullough Foundation The Wellness Company Peter A. McCullough, MD, MPH® Harvey Risch Kelly Victory MD James Thorp MD Dr. Drew Peter Gillooly Foster Coulson

🚨NEARLY HALF OF CANCER PATIENTS TAKING IVERMECTIN + MEBENDAZOLE REPORTED CANCER DISAPPEARANCE OR TUMOR REGRESSION AFTER 6 MONTHS 84.4% EXPERIENCED CLINICAL BENEFIT 32.8% REPORTED NO EVIDENCE OF DISEASE 15.6% REPORTED TUMOR REGRESSION 36.1% REPORTED STABLE DISEASE Our study represents the largest and most compelling clinical signal to date supporting antiparasitic therapy in cancer. McCullough Foundation The Wellness Company Peter A. McCullough, MD, MPH® Harvey Risch Kelly Victory MD James Thorp MD Dr. Drew Peter Gillooly Foster Coulson

Nicolas Hulscher, MPH

764,412 views • 5 months ago

It’s no wonder the CIA BURIED a 1950s study for over HALF A CENTURY showing anti-parasitics SUPPRESS cancer growth.... Our study found 84.4% of cancer patients taking ivermectin + mebendazole declared their cancer either DISAPPEARED, REGRESSED, or STOPPED SPREADING.

It’s no wonder the CIA BURIED a 1950s study for over HALF A CENTURY showing anti-parasitics SUPPRESS cancer growth.... Our study found 84.4% of cancer patients taking ivermectin + mebendazole declared their cancer either DISAPPEARED, REGRESSED, or STOPPED SPREADING.

Nicolas Hulscher, MPH

44,655 views • 4 months ago

The largest peer-reviewed study to date of 197 cancer patients was just published. This study examines the adjunctive use of Ivermectin + Mebendazole for cancer and the findings are beginning to support further investigation for their off-label uses. I've been talking about this hard-to-get combo for about a year now. I've taken it myself and will be recommending it to all of my family and friends. Learn more at the link in my bio and check out the study yourself. Code TRUTHSEEKER saves you $60.

The largest peer-reviewed study to date of 197 cancer patients was just published. This study examines the adjunctive use of Ivermectin + Mebendazole for cancer and the findings are beginning to support further investigation for their off-label uses. I've been talking about this hard-to-get combo for about a year now. I've taken it myself and will be recommending it to all of my family and friends. Learn more at the link in my bio and check out the study yourself. Code TRUTHSEEKER saves you $60.

TruthSeeker01011

37,722 views • 3 months ago

Finding an 84.4% CLINICAL BENEFIT with ivermectin and mebendazole in cancer was just the beginning... Imaging-confirmed COMPLETE REMISSIONS of cancer using antiparasitics—WITHOUT chemo, surgery, or radiation—are soon to be published. Stay tuned.

Finding an 84.4% CLINICAL BENEFIT with ivermectin and mebendazole in cancer was just the beginning... Imaging-confirmed COMPLETE REMISSIONS of cancer using antiparasitics—WITHOUT chemo, surgery, or radiation—are soon to be published. Stay tuned.

Nicolas Hulscher, MPH

57,171 views • 5 months ago

Great to see Dr Joe Ladapo and Dr William Makis collaborating on the use of ivermectin/fenbendezole in cancer treatment. Studies that verify the astonishing findings of Dr Makis. Who is treating over 6000 patients with great success in early stages of cancer. Achieving remission or significant shrinkage in tumours. Even having some success with stage 4 cancers. The Fenbendazole study showing patients going from stage 4 to cancer free and remained so up to 3 years. ‘That’s why the research is so important so that we can prove these things that I’m seeing in my clinic.’

Great to see Dr Joe Ladapo and Dr William Makis collaborating on the use of ivermectin/fenbendezole in cancer treatment. Studies that verify the astonishing findings of Dr Makis. Who is treating over 6000 patients with great success in early stages of cancer. Achieving remission or significant shrinkage in tumours. Even having some success with stage 4 cancers. The Fenbendazole study showing patients going from stage 4 to cancer free and remained so up to 3 years. ‘That’s why the research is so important so that we can prove these things that I’m seeing in my clinic.’

Kat A 🌸

39,866 views • 11 months ago